ClinicalTrials.gov
ClinicalTrials.gov Menu

Free Radical Level in SCC of Tongue Patients Tumor, Serum and Saliva

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00426062
Recruitment Status : Unknown
Verified February 2007 by Sheba Medical Center.
Recruitment status was:  Recruiting
First Posted : January 24, 2007
Last Update Posted : February 21, 2007
Sponsor:
Information provided by:
Sheba Medical Center

Brief Summary:
Study comparing level of free radicals in tumor tissue, blood serum and saliva in patients with Squamous Cell Carcinoma of tongue and mouth floor. Patients with benign fibroma of oral cavity and normal gingiva around extracted lower wisdom tooth are used for control

Condition or disease
Squamous Cell Carcinoma

Study Type : Observational
Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by the National Library of Medicine

U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  1. Older than 18 years of age.
  2. Mentally healthy
  3. SCC of Tongue or Mouth Floor
  4. Benign Fibroma of Oral Cavity
  5. Lower wisdom tooth extraction -

Exclusion Criteria:

  1. Younger than 18 years of age
  2. Mentally incapacitated

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00426062


Contacts
Contact: Alex Dobriyan, DMD 972-3-6040306 lancet72@gmail.com
Contact: Ran Yahalom, DMD 972-3-5303819 ranyahalom@gmail.com

Locations
Israel
Sheba Medical Center Recruiting
Ramat Gan, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Alex Dobriyan, DMD Sheba Medical Center
Principal Investigator: Ran Yahalom, DMD Sheba Medical Center
Principal Investigator: Rafi Nagler, DMD,MD Rambam Health Care Campus

ClinicalTrials.gov Identifier: NCT00426062     History of Changes
Other Study ID Numbers: SHEBA-06-4116-AD-CTIL
First Posted: January 24, 2007    Key Record Dates
Last Update Posted: February 21, 2007
Last Verified: February 2007

Keywords provided by Sheba Medical Center:
Squamous Cell Carcinoma of Tongue and mouth floor

Additional relevant MeSH terms:
Carcinoma, Squamous Cell
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Squamous Cell